Diagnostics Company SIRS-Lab insolvent

Investor search for Molecular Diagnostics Company started

14-Jan-2013 - SIRS-Lab requested the opening of insolvency proceedings. The company, founded ten years ago, develops molecular diagnostic technologies for life-threatening infections as sepsis, also known as blood poisoning. Sepsis claims 250.000 victims per year in the USA alone. Therefore SIRS-Lab has ...

First Patient Included in Multicenter Study to Evaluate SIRS-Lab’s Diagnostic Test for Blood-Stream Infection

24-Mar-2011 - SIRS-Lab announced the inclusion of the first patient in a 1000-patient clinical study evaluating their molecular pathogen test VYOO. The multicenter trial, performed in 11 key centers across Germany and initiated in February 2011, will deliver data about the utility of the PCR test compared to ...

SIRS-Lab and Analytik Jena cooperate on Sepsis Diagnostics

17-Jun-2010 - SIRS-Lab GmbH and Analytik Jena AG will be strengthened by working together in the field of molecular sepsis diagnostics. As part of this cooperation, Analytik Jena subsidiary AJ Innuscreen GmbH will provide the partner with a platform for automated isolation of nucleic acids with the associated ...

Board elects new CEO to molecular diagnostics company SIRS-Lab GmbH

10-Aug-2009 - SIRS-Lab GmbH has elected Barbara Staehelin as new Chief Executive Officer. Swiss national Barbara Staehelin is a biochemist and holds an MBA from INSEAD (Fontainebleau). She is a life science entrepreneur and has also made a career in the diagnostics industry. Until 2006, she was a member of the ...